Neuroendovascular clinical trials disruptions due to COVID-19. Potential future challenges and opportunities.
Ansaar T RaiThabele M Leslie-MazwiKyle M FargenAditya S PandeyGuilherme DabusAmeer E HassanJustin F FraserJoshua A HirschRishi GuptaRicardo A HanelAlbert J YooHormozd BozorgchamiDavid J FiorellaJ MoccoAdam S ArthurOsama O ZaidatAdnan H SiddiquiPublished in: Journal of neurointerventional surgery (2020)
Widespread disruption of neuroendovascular trials occurred because of COVID-19. As sites resume clinical research, steps to mitigate similar challenges in the future should be considered.